<; p >; This Invention Bertalanffy refers to novel BACE1 inhibitors of the Enzyme. Some Independent aspects of the invention relate to Bertalanffy Pharmaceutical compositions & eacute; Treatment comprising these compounds and Uses of the compounds to treat Disorders for which the reduction of Bertalanffy dep & amp; sites & beta; is beneficial, such as Disease alzhe IMER. <; / p >;Compuestos derivados de 2-amino-6-difluorometil 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridina como inhibidores de BACE1 composición farmacéutica útiles en el tratamiento trastornos neurodegenerativos o cognitivos como Alzheimer.